Cerebain Biotech Announces Engagement of IDC Consulting for Representation in Uzbekistan  
6/25/2013 11:32:46 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DALLAS--(BUSINESS WIRE)--Cerebain Biotech Corp. (“Cerebain” or “the Company”), a subsidiary of Discount Dental Materials, Inc. (OTCBB: DDOO), announced today that it has engaged IDC Consulting to represent the Company in Uzbekistan for the purpose of Clinical Testing of the Company’s Medical Device for the treatment of Alzheimer’s Disease utilizing the Omentum. IDC Consulting will serve as the intermediary in Uzbekistan to determine and finalize any required local approvals and establish essential partnerships with Doctors and Medical Facilities necessary for this testing once the Company’s prototype is completed. The medical device is being developed by Cerebain Biotech Corp. as a potential new approach to the treatment for patients suffering from Alzheimer’s and Dementia.

Help employers find you! Check out all the jobs and post your resume.